UPDATE 1-TABLE-GTx Q4 loss narrows; gives '07 view

(Adds 2007 outlook)

Feb 20 (Reuters) -

GTX INC. (GTXI.O)

Latest Yr ago

qtr
Loss (diluted, $/shr) 0.15 0.26
Net loss ($ million) 4.7 7.8
Total revenue
($ thousands) 4,600 646

*Source: Reuters Estimates

--The biopharmaceutical company said revenue for the latest
fourth quarter included recognition of the remaining deferred
revenue of $3.3 million from collaboration with Ortho Biotech
Products L. P. and collaboration income of $1.5 million from
Ipsen Ltd.

--For the latest fourth quarter, analysts had on average
expected the company to post a loss of 35 cents a share,
excluding exceptional items, on revenue of $2.05 million,
according to Reuters Estimates.

--GTx expects net loss of $45 million to $55 million for
2007. The outlook includes the continuation of two late-stage
Acapodene clinical trials and two mid-stage Ostarine trials
which will be initiated this year, the company said.
(Reporting by Aditi Samajpati in Bangalore)